By blocking the main receptor of VEGF-A (VEGFR-2) with a kinase inhibitor SU1498 (5; Figure 2), there was a significant reduction of vascular permeability in CDI mice, and significantly attenuated weight loss. This evidence concerns the gene VEGFA and clostridium difficile infection.